NDC 49230-209
DELFLEX Neutral pH
Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate
DELFLEX Neutral pH is a Intraperitoneal Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Medical Care North America. The primary component is Dextrose Monohydrate; Sodium Chloride; Sodium Lactate; Calcium Chloride; Magnesium Chloride.
| Product ID | 49230-209_494d8150-addd-11e2-9e96-0800200c9a66 |
| NDC | 49230-209 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DELFLEX Neutral pH |
| Generic Name | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
| Dosage Form | Solution |
| Route of Administration | INTRAPERITONEAL |
| Marketing Start Date | 1992-08-19 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020171 |
| Labeler Name | Fresenius Medical Care North America |
| Substance Name | DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM LACTATE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE |
| Active Ingredient Strength | 3 g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 49230-209-92
5 BAG in 1 CARTON (49230-209-92) > 2000 mL in 1 BAG
| Marketing Start Date | 1992-08-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49230-209-98 [49230020998]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2013-10-25 |
NDC 49230-209-91 [49230020991]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2015-08-13 |
NDC 49230-209-94 [49230020994]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-08-19 |
NDC 49230-209-30 [49230020930]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-08-19 |
NDC 49230-209-25 [49230020925]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2015-08-13 |
NDC 49230-209-60 [49230020960]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
NDC 49230-209-95 [49230020995]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-08-19 |
NDC 49230-209-97 [49230020997]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2019-05-22 |
NDC 49230-209-90 [49230020990]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2015-08-13 |
NDC 49230-209-51 [49230020951]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2019-05-22 |
NDC 49230-209-31 [49230020931]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2013-10-25 |
NDC 49230-209-96 [49230020996]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2013-10-25 |
NDC 49230-209-15 [49230020915]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2015-08-13 |
NDC 49230-209-23 [49230020923]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
NDC 49230-209-50 [49230020950]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-08-19 |
NDC 49230-209-92 [49230020992]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1992-08-19 |
NDC 49230-209-93 [49230020993]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2015-08-13 |
NDC 49230-209-61 [49230020961]
DELFLEX SOLUTION
| Marketing Category | NDA |
| Application Number | NDA020171 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1992-08-19 |
| Marketing End Date | 2019-05-22 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| DEXTROSE MONOHYDRATE | 2.5 g/100mL |
OpenFDA Data
| SPL SET ID: | 6da01480-39a9-11e2-b5eb-0002a5d5c51b |
| Manufacturer | |
| UNII |
Pharmacological Class
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Osmotic Laxative [EPC]
- Increased Large Intestinal Motility [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
- Osmotic Activity [MoA]
- Blood Coagulation Factor [EPC]
- Increased Coagulation Factor Activity [PE]
- Calcium [CS]
- Cations
- Divalent [CS]
- Calculi Dissolution Agent [EPC]
- Magnesium Ion Exchange Activity [MoA]
- Osmotic Laxative [EPC]
- Osmotic Activity [MoA]
- Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
- Increased Large Intestinal Motility [PE]
- Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
NDC Crossover Matching brand name "DELFLEX Neutral pH" or generic name "Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49230-188 | DELFLEX | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
| 49230-191 | DELFLEX | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
| 49230-194 | DELFLEX | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
| 49230-197 | DELFLEX | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
| 49230-200 | DELFLEX | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
| 49230-203 | DELFLEX | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
| 49230-206 | DELFLEX | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
| 49230-209 | DELFLEX | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
| 49230-212 | DELFLEX | Dextrose Monohydrate, Sodium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Lactate |
Trademark Results [DELFLEX]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 DELFLEX 78560327 3054723 Live/Registered |
Fresenius Medical Care Holdings, Inc. 2005-02-03 |
 DELFLEX 74094930 1687522 Dead/Cancelled |
Delmed Inc. 1990-09-06 |
 DELFLEX 72352463 0922661 Dead/Expired |
DELTA STRAPPING INDUSTRIES, INC. 1970-02-26 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.